Serveur d'exploration sur les relations entre la France et l'Australie - Corpus (PubMed)

Index « MedMesh.i » - entrée « Viral Load »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Viral Envelope Proteins < Viral Load < Viral Nonstructural Proteins  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000224 (2017) Julianne Bayliss ; Lilly Yuen ; Gillian Rosenberg ; Darren Wong ; Margaret Littlejohn ; Kathleen Jackson ; Anuj Gaggar ; Kathryn M. Kitrinos ; G Mani Subramanian ; Patrick Marcellin ; Maria Buti ; Harry L A. Janssen ; Ed Gane ; Vitina Sozzi ; Danni Colledge ; Rachel Hammond ; Rosalind Edwards ; Stephen Locarnini ; Alexander Thompson ; Peter A. RevillDeep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
000C16 (2017) Georgios Theocharopoulos ; Kostas Danis ; Jane Greig ; Alexandra Hoffmann ; Henriette De Valk ; Augustine Jimissa ; Sumaila Tejan ; Mohammed Sankoh ; Karline Kleijer ; Will Turner ; Jay Achar ; Jennifer Duncombe ; Kamalini Lokuge ; Ivan Gayton ; Rob Broeder ; Ronald Kremer ; Grazia CaleoEbola management centre proximity associated with reduced delays of healthcare of Ebola Virus Disease (EVD) patients, Tonkolili, Sierra Leone, 2014-15.
001359 (2017) Mark A. Boyd ; Janaki Amin ; Patrick W G. Mallon ; Nagalingeswaran Kumarasamy ; Johan Lombaard ; Robin Wood ; Ploenchan Chetchotisakd ; Praphan Phanuphak ; Lerato Mohapi ; Iskandar Azwa ; Waldo H. Belloso ; Jean-Michel Molina ; Jennifer Hoy ; Cecilia L. Moore ; Sean Emery ; David A. CooperBody composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
001457 (2016) Jason Grebely ; Stefan Mauss ; Ashley Brown ; Jean-Pierre Bronowicki ; Massimo Puoti ; David Wyles ; Macky Natha ; Yanni Zhu ; Junming Yang ; Bruce Kreter ; Diana M. Brainard ; Chohee Yun ; Val Carr ; Gregory J. DoreEfficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials.
001974 (2016) Cécile H. Herbreteau ; Mélanie Denizot ; Suzanne Lowther ; Sarah Riddell ; Leah Frazer ; Jessica Haining ; Rachel Arkinstall ; Jean Payne ; Jenni Harper ; Dayna Johnson ; Anaïs Pasquier ; Deborah Middleton ; Jean-François SaluzzoEfficacy of a specific polyclonal equine F(ab')2 against avian influenza (H5N1) in ferrets: synergy with oseltamivir.
001C06 (2016) Sarah Lilian Pett ; Janaki Amin ; Andrejz Horban ; Jaime Andrade-Villanueva ; Marcelo Losso ; Norma Porteiro ; Juan Sierra Madero ; Waldo Belloso ; Elise Tu ; David Silk ; Anthony Kelleher ; Richard Harrigan ; Andrew Clark ; Wataru Sugiura ; Marcelo Wolff ; John Gill ; Jose Gatell ; Martin Fisher ; Amanda Clarke ; Kiat Ruxrungtham ; Thierry Prazuck ; Rolf Kaiser ; Ian Woolley ; Juan Alberto Arnaiz ; David Cooper ; Jürgen K. Rockstroh ; Patrick Mallon ; Sean EmeryMaraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.
001E20 (2016) Michael Manns ; Didier Samuel ; Edward J. Gane ; David Mutimer ; Geoff Mccaughan ; Maria Buti ; Martín Prieto ; José Luis Calleja ; Markus Peck-Radosavljevic ; Beat Müllhaupt ; Kosh Agarwal ; Peter Angus ; Eric M. Yoshida ; Massimo Colombo ; Mario Rizzetto ; Hadas Dvory-Sobol ; Jill Denning ; Sarah Arterburn ; Phillip S. Pang ; Diana Brainard ; John G. Mchutchison ; Jean-François Dufour ; Hans Van Vlierberghe ; Bart Van Hoek ; Xavier FornsLedipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.
001F40 (2016) Lloyd Einsiedel ; Olivier Cassar ; Tim Spelman ; Sheela Joseph ; Antoine GessainHigher HTLV-1c proviral loads are associated with blood stream infections in an Indigenous Australian population.
002103 (2016) Romain Palich ; Jean-Luc Gala ; Frédéric Petitjean ; Susan Shepherd ; Olivier Peyrouset ; Bing M. Abdoul ; Moumouni Kinda ; Christine Danel ; Augustin Augier ; Xavier Anglaret ; Denis Malvy ; Nicole BlackwellA 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea.
002176 (2016) Tarik Asselah ; Alex J. Thompson ; Robert Flisiak ; Manuel Romero-Gomez ; Diethelm Messinger ; Georgios Bakalos ; Mitchell L. ShiffmanA Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.
002545 (2016) Patrick Marcellin ; Sang Hoon Ahn ; Xiaoli Ma ; Florin A. Caruntu ; Won Young Tak ; Magdy Elkashab ; Wan-Long Chuang ; Seng-Gee Lim ; Fehmi Tabak ; Rajiv Mehta ; Joerg Petersen ; Graham R. Foster ; Lillian Lou ; Eduardo B. Martins ; Phillip Dinh ; Lanjia Lin ; Amoreena Corsa ; Prista Charuworn ; G Mani Subramanian ; Hans Reiser ; Hendrick W. Reesink ; Scott Fung ; Simone I. Strasser ; Huy Trinh ; Maria Buti ; Giovanni B. Gaeta ; Aric J. Hui ; George Papatheodoridis ; Robert Flisiak ; Henry L Y. ChanCombination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B.
002755 (2015) Paul J. Mclaren ; Cedric Coulonges ; István Bartha ; Tobias L. Lenz ; Aaron J. Deutsch ; Arman Bashirova ; Susan Buchbinder ; Mary N. Carrington ; Andrea Cossarizza ; Judith Dalmau ; Andrea De Luca ; James J. Goedert ; Deepti Gurdasani ; David W. Haas ; Joshua T. Herbeck ; Eric O. Johnson ; Gregory D. Kirk ; Olivier Lambotte ; Ma Luo ; Simon Mallal ; Daniëlle Van Manen ; Javier Martinez-Picado ; Laurence Meyer ; José M. Miro ; James I. Mullins ; Niels Obel ; Guido Poli ; Manjinder S. Sandhu ; Hanneke Schuitemaker ; Patrick R. Shea ; Ioannis Theodorou ; Bruce D. Walker ; Amy C. Weintrob ; Cheryl A. Winkler ; Steven M. Wolinsky ; Soumya Raychaudhuri ; David B. Goldstein ; Amalio Telenti ; Paul I W. De Bakker ; Jean-François Zagury ; Jacques FellayPolymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.
002825 (2015) Joy Gardner ; Penny A. Rudd ; Natalie A. Prow ; Essia Belarbi ; Pierre Roques ; Thibaut Larcher ; Lionel Gresh ; Angel Balmaseda ; Eva Harris ; Wayne A. Schroder ; Andreas SuhrbierInfectious Chikungunya Virus in the Saliva of Mice, Monkeys and Humans.
002A81 (2015) Jürgen K. Rockstroh ; Mark Nelson ; Christine Katlama ; Jay Lalezari ; Josep Mallolas ; Mark Bloch ; Gail V. Matthews ; Michael S. Saag ; Philippe J. Zamor ; Chloe Orkin ; Jacqueline Gress ; Stephanie Klopfer ; Melissa Shaughnessy ; Janice Wahl ; Bach-Yen T. Nguyen ; Eliav Barr ; Heather L. Platt ; Michael N. Robertson ; Mark SulkowskiEfficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial.
002C95 (2015) Christophe Hézode ; Gideon M. Hirschfield ; Wayne Ghesquiere ; William Sievert ; Maribel Rodriguez-Torres ; Stephen D. Shafran ; Paul J. Thuluvath ; Harvey A. Tatum ; Imam Waked ; Gamal Esmat ; Eric J. Lawitz ; Vinod K. Rustgi ; Stanislas Pol ; Nina Weis ; Paul J. Pockros ; Marc Bourlière ; Lawrence Serfaty ; John M. Vierling ; Michael W. Fried ; Ola Weiland ; Maurizia R. Brunetto ; Gregory T. Everson ; Stefan Zeuzem ; Paul Y. Kwo ; Mark Sulkowski ; Norbert Br U ; Dennis Hernandez ; Fiona Mcphee ; Megan Wind-Rotolo ; Zhaohui Liu ; Stephanie Noviello ; Eric A. Hughes ; Philip D. Yin ; Steven SchnittmanDaclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study.
002D63 (2015) Andrew J. Muir ; Fred Poordad ; Jacob Lalezari ; Gregory Everson ; Gregory J. Dore ; Robert Herring ; Aasim Sheikh ; Paul Kwo ; Christophe Hézode ; Paul J. Pockros ; Albert Tran ; Joseph Yozviak ; Nancy Reau ; Alnoor Ramji ; Katherine Stuart ; Alexander J. Thompson ; John Vierling ; Bradley Freilich ; James Cooper ; Wayne Ghesquiere ; Rong Yang ; Fiona Mcphee ; Eric A. Hughes ; E Scott Swenson ; Philip D. YinDaclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis.
002F36 (2015) Jean-Michel Molina ; Chloe Orkin ; David M. Iser ; Francisco-Xavier Zamora ; Mark Nelson ; Christoph Stephan ; Benedetta Massetto ; Anuj Gaggar ; Liyun Ni ; Evguenia Svarovskaia ; Diana Brainard ; G Mani Subramanian ; John G. Mchutchison ; Massimo Puoti ; Jürgen K. RockstrohSofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study.
002F88 (2015) Eric Lawitz ; Edward Gane ; Brian Pearlman ; Edward Tam ; Wayne Ghesquiere ; Dominique Guyader ; Laurent Alric ; Jean-Pierre Bronowicki ; Laura Lester ; William Sievert ; Reem Ghalib ; Luis Balart ; Fredrik Sund ; Martin Lagging ; Frank Dutko ; Melissa Shaughnessy ; Peggy Hwang ; Anita Y M. Howe ; Janice Wahl ; Michael Robertson ; Eliav Barr ; Barbara HaberEfficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial.
003039 (2015) Mark A. Boyd ; Cecilia L. Moore ; Jean-Michel Molina ; Robin Wood ; Juan S. Madero ; Marcelo Wolff ; Kiat Ruxrungtham ; Marcelo Losso ; Boris Renjifo ; Hedy Teppler ; Anthony D. Kelleher ; Janaki Amin ; Sean Emery ; David A. CooperBaseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.
003175 (2015) Marcel Yotebieng ; Tammy Meyers ; Frieda Behets ; Mary-Ann Davies ; Olivia Keiser ; Kapella Zacharia Ngonyani ; Rita E. Lyamuya ; Azar Kariminia ; Rawiwan Hansudewechakul ; Valeriane Leroy ; Sikiratou Koumakpai ; Jamie Newman ; Annelies Van RieAge-specific and sex-specific weight gain norms to monitor antiretroviral therapy in children in low-income and middle-income countries.
003516 (2014) Azar Kariminia ; Nicolas Durier ; Gonzague Jourdain ; Suneeta Saghayam ; Chau V. Do ; Lam Van Nguyen ; Rawiwan Hansudewechakul ; Pagakrong Lumbiganon ; Kulkanya Chokephaibulkit ; Khanh Huu Truong ; Virat Sirisanthana ; Vibol Ung ; Saphonn Vonthanak ; Jintanat Ananworanich ; Nik Khairulddin Nik Yusoff ; Nia Kurniati ; Kamarul Azahar Razali ; Moy Siew Fong ; Revathy Nallusamy ; Dewi Kumara WatiWeight as predictors of clinical progression and treatment failure: results from the TREAT Asia Pediatric HIV Observational Database.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Viral Load" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Viral Load" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Viral Load
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024